Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generative AI Simulation for Diagnostic Communication in Type 2 Diabetes: A Randomized Controlled Trial (DIALOGUE-DM2)

NCT07252193 is registered in ClinicalTrials.gov with Universidad Nacional Autonoma de Mexico as lead sponsor.

NCT NCT07252193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07252193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generative AI Simulation for Diagnostic Communication in Type 2 Diabetes: A Randomized Controlled Trial (DIALOGUE-DM2)
Lead sponsor
Universidad Nacional Autonoma de Mexico
Phase
Not applicable
Overall status
Completed
Start date
September 22, 2025
Completion date
December 20, 2025
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence simulation, diagnostic communication, medical education, type 2 diabetes mellitus